(Q34113615)

31 July 2017

1 reference

title

Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins (English)

1 reference

31 July 2017

1 reference

1

1 reference

31 July 2017

publication date

1 August 2010

1 reference

Clinical Chemistry and Laboratory Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

48

1 reference

31 July 2017

issue

8

1 reference

31 July 2017

page(s)

1063-1073

1 reference

Crosstalk among multiple signal-activated phospholipases

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Lipid inflammatory mediators in diabetic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Vascular cytochrome p450 enzymes: physiology and pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

COX-2 inhibitors and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Reconstitution of ATP-dependent leukotriene C4 transport by Co-expression of both half-molecules of human multidrug resistance protein in insect cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

5-Lipoxygenase: mechanisms of regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

The nuclear membrane organization of leukotriene synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4synthetic capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Phosphorylation by protein kinase a inhibits nuclear import of 5-lipoxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Phosphorylation of serine 271 on 5-lipoxygenase and its role in nuclear export.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

TH2 and 'TH2-like' cells in allergy and asthma: pharmacological perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Trihydroxytetraenes: a novel series of compounds formed from arachidonic acid in human leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

The activity of PPAR gamma in primary human trophoblasts is enhanced by oxidized lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Aspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A4 formation: a randomized human trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Anti-inflammatory and proresolving lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Selective survival rescue in 15-lipoxygenase-1-deficient retinal pigment epithelial cells by the novel docosahexaenoic acid-derived mediator, neuroprotectin D1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

15-oxo-Eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Structure, biochemistry and biology of hepoxilins: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Prostaglandins and leukotrienes: advances in eicosanoid biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Leukotriene modifiers as potential therapeutics for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Leukotrienes C4, D4 and E4 cause widespread and extensive plasma extravasation in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Treatment of asthma with antileukotrienes: first line or last resort therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Neuroprotectin D1 inhibits retinal ganglion cell death following axotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Association between 5-lipoxygenase expression and plaque instability in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Participation of 5-lipoxygenase-derived LTB(4) in 4-hydroxynonenal-enhanced MMP-2 production in vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Leukotriene receptors in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Arachidonate 5-lipoxygenase (5-LO) promoter genotype and risk of myocardial infarction: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Genetic variation in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) is associated with myocardial infarction in the German population

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of stroke: a HuGE gene-disease association review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Anti-atherogenic effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Leukotriene pathway genetics and pharmacogenetics in allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Leukotriene C4 synthase and ischemic cardiovascular disease and obstructive pulmonary disease in 13,000 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

The two faces of the 15-lipoxygenase in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Anti-inflammatory lipid mediators and insights into the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Oxygenation of lipoproteins by mammalian lipoxygenases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Essential involvement of 12-lipoxygenase in regiospecific andstereospecific oxidation of low density lipoprotein by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Dual 12/15- and 5-lipoxygenase deficiency in macrophages alters arachidonic acid metabolism and attenuates peritonitis and atherosclerosis in ApoE knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Uptake and subcellular distribution of [3H]arachidonic acid in murine fibrosarcoma cells measured by electron microscope autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Functional polymorphism in ALOX15 results in increased allele-specific transcription in macrophages through binding of the transcription factor SPI1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

No association of two functional polymorphisms in human ALOX15 with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Dihydroxydocosahexaenoic acids of the neuroprotectin D family: synthesis, structure, and inhibition of human 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

Leukotriene B4production in healthy subjects carrying variants of the arachidonate 5-lipoxygenase-activating protein gene associated with a risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.212

21 January 2018

Identifiers

DOI

10.1515/CCLM.2010.212

1 reference

31 July 2017

1 reference